Numico's claims present a host of problems.  The patent of the human milk
component(from which this company can make these claims) is described as a
anti-diarrheic product, an anti-rotaviral agent.  This component is described
as  an anti-rotaviral agent such as human defatted fat globule membranes, the
human milk macromolecuilar fraction, the milk mucin complex, the 46 KD
apparent MW glycoprotein, or mixtures thereof, and optimally skim milk, curd,
and or whey.  Notice the "such as" which means to me that they are not
necessarily using human milk.  Product usage is for infants and children,
travelers, and immundeficient persons, including HIV positive and transplant
patients.

I have a feeling this may be a court battle in the making because they can
claim its closeness to human milk.  How will we, breastfeeding advocates,
respond?  They, the formula companies aren't lying.  The issues are about
biotechnology and how what people are willing to allow in the pursuit of new
products and markets.  Valerie W. McClain, IBCLC

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html